According to GLOBOCAN 2020 data, over 2 mln breast cancer cases yearly are noticed worldwide. At the same time, breast cancer took the lives of almost 700 thousand people.
Medical science believe that effective and fast detection of the illness would save the lives of many patients around the world. That’s why we created and developed the inPROBE medical device, first ever optic fibre microprobe, enabling in vivo real-time breast cancer diagnosis.
Our vision to “increase the cancer cure rate by 30% by 2030” is an indissoluble part of our DNA – connecting and motivating the whole SDS Optic team.
The SDS Optic team is working on a breakthrough technology based on rapid detection of test substances in the body, including cancer markers, with particular accuracy, the using laser beams and innovative components. At the end of the process, the reading is interpreted on the detector by means of an appropriate conversion algorithm, which gives the level of the compound tested (e.g. HER2 cancer marker) in numerical form.
Our technology is a breakthrough. We create inPROBE a tool for direct measurement of the HER2 marker. The use of a microsonde will save the patient pain and stress associated with a biopsy and waiting for the result. We want to save up to 30% of people diagnosed with cancer by 2030